Novartis Units Pay $346M Over US Bribery Claims

By Jody Godoy · June 25, 2020, 1:33 PM EDT

Current and former subsidiaries of pharmaceutical giant Novartis AG have agreed to pay $345.9 million in penalties and profits over an alleged bribery scheme at hospitals in Greece and improper record-keeping...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Jody

July 21, 2020
2 Chinese Nationals Accused Of Hacking COVID-19 Research
June 30, 2020
Ex-Indivior CEO Cops To Misdemeanor In Opioid Case
June 29, 2020
Feds Say Atty Exploited Rural Hospitals To Cover $1.4B Fraud
May 11, 2020
Feds Float Added Charge Against Ex-Theranos CEO
April 10, 2020
2nd Circ. Won't Rehear Deerfield Insider Trading Appeal
April 01, 2020
2nd Circ. Rejects Sheldon Silver's Bid To Delay Sentencing
March 31, 2020
Ex-Theranos CEO Wants Trial Prep OK'd Amid Pandemic
March 30, 2020
Patient Recruiter Got Kickbacks For COVID-19 Tests, Feds Say
March 04, 2020
Cross-Border Probes Slowing Amid Coronavirus Precautions
February 21, 2020
Congress Probes Civil Rights Issues In China Investigations